Octave Bioscience Appoints Marcel Konrad as Chief Financial Officer and Adds Several New Commercial Leaders
Position
Chief Financial Officer
Company
Octave Bioscience
Menlo ParkBiotechnologyHealthcareDescription
Octave Bioscience, a leading precision care company, has appointed Marcel Konrad as Chief Financial Officer, who brings a distinguished track record in scaling high-growth therapeutic and diagnostic companies. The company has also made several new appointments of proven commercial leaders, including CEO Doug Biehn, Chief Revenue Officer Jeron Evans, and Chief Access Officer Debbie Ledet.
Quick answer
Octave Bioscience Appoints Marcel Konrad as Chief Financial Officer and Adds Several New Commercial Leaders (August 7, 2024). Octave Bioscience is based in Menlo Park, California, United States.
- Who is the new Chief Financial Officer at Octave Bioscience?
- Octave Bioscience named Marcel Konrad Chief Financial Officer, announced August 7, 2024.
- What did Octave Bioscience announce on August 7, 2024?
- Octave Bioscience, a leading precision care company, has appointed Marcel Konrad as Chief Financial Officer, who brings a distinguished track record in scaling high-growth therapeutic and diagnostic companies. The company has also made several new appointments of proven commercial leaders, including CEO Doug Biehn, Chief Revenue Officer Jeron Evans, and Chief Access Officer Debbie Ledet.
- What does Octave Bioscience do?
- Octave Bioscience, Inc. is a commercial growth stage precision medicine company pioneering biomarker-driven solutions for neurodegenerative diseases, with an initial focus on Multiple Sclerosis, and Parkinson’s Disease...
- Where is Octave Bioscience based?
- Octave Bioscience is based in Menlo Park, California, United States.
- Which similar companies made leadership changes around the same time?
- Equinox (August 1, 2024), Jade Biosciences (August 1, 2024), PepGen (August 20, 2024) and PRECIGEN, INC. (July 23, 2024) also announced leadership changes within 45 days of Octave Bioscience.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Equinox Appoints Marc Mastronardi as President (August 1, 2024)
- Jade Biosciences Names Andrew King as Chief Scientific Officer (August 1, 2024)
- PepGen Inc. Appoints Paul Streck, M.D., MBA as Executive Vice President, Head of Research & Development (August 20, 2024)
- Precigen, Inc. Appoints Phil Tennant as Chief Commercial Officer (July 23, 2024)
- ReAlta Life Sciences, Inc. Appoints David Marek as Chief Executive Officer and Paolo Martini, Ph.D., as Chief Research and Development Officer (August 22, 2024)
- Eliem Therapeutics Appoints Brett Kaplan, M.D. as Chief Operating Officer and Nishi Rampal, M.D. as Senior Vice President, Clinical Development (August 26, 2024)
Who to call at Octave Bioscience, and when
A new leader at Octave Bioscience brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Octave Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Octave Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Octave Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Octave Bioscience changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Octave Bioscience changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.